VERTEX PHARMACEUTICALS INC / MA Increase (Decrease) in Accounts Receivable
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Increase (Decrease) in Accounts Receivable of $100.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $140.20M, a 661.96% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$39.80M, a 123.47% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $99.40M.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $59.90M, a 15.64% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for fiscal 2025 was $347.30M, a 249.75% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for fiscal 2024 was $99.30M, a 18.07% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for fiscal 2023 was $84.10M, a 76.55% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts receivable for fiscal 2022 was $358.60M, a 30.54% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $140.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $100.40M 10-Q · filed 2026-08-04 | $199.80M derived: sum of 3 quarters · filed 2026-08-04 | $259.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$39.80M 10-Q · filed 2026-05-05 | $59.60M derived: sum of 2 quarters · filed 2026-05-05 | $119.50M derived: sum of 3 quarters · filed 2026-05-05 | $137.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $99.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $159.30M derived: sum of 2 quarters · filed 2026-02-13 | $177.70M derived: sum of 3 quarters · filed 2026-08-04 | $347.30M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $59.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $78.30M derived: sum of 2 quarters · filed 2026-08-04 | $247.90M 10-Q · filed 2025-11-04 | $178.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $18.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $188.00M 10-Q · filed 2026-08-04 | $119.00M derived: sum of 3 quarters · filed 2026-08-04 | $170.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $169.60M 10-Q · filed 2026-05-05 | $100.60M derived: sum of 2 quarters · filed 2026-05-05 | $152.40M derived: sum of 3 quarters · filed 2026-05-05 | $17.30M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$17.20M derived: sum of 2 quarters · filed 2026-02-13 | -$152.30M derived: sum of 3 quarters · filed 2026-02-13 | $99.30M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $51.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$83.30M derived: sum of 2 quarters · filed 2025-11-04 | $168.30M 10-Q · filed 2025-11-04 | $152.90M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$135.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $116.50M 10-Q · filed 2025-08-05 | $101.10M derived: sum of 3 quarters · filed 2026-02-13 | $107.20M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $251.60M 10-Q · filed 2025-05-06 | $236.20M derived: sum of 2 quarters · filed 2026-02-13 | $242.30M derived: sum of 3 quarters · filed 2026-02-13 | $245.20M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | -$15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$9.30M derived: sum of 2 quarters · filed 2026-02-13 | -$6.40M derived: sum of 3 quarters · filed 2026-02-13 | $84.10M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $6.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $9.00M derived: sum of 2 quarters · filed 2024-11-05 | $99.50M 10-Q · filed 2024-11-05 | $89.30M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $93.40M 10-Q · filed 2024-08-02 | $83.20M derived: sum of 3 quarters · filed 2025-02-13 | $202.70M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $90.50M 10-Q · filed 2024-05-07 | $80.30M derived: sum of 2 quarters · filed 2025-02-13 | $199.80M derived: sum of 3 quarters · filed 2025-02-13 | $283.90M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $109.30M derived: sum of 2 quarters · filed 2025-02-13 | $193.40M derived: sum of 3 quarters · filed 2025-02-13 | $358.60M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $119.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $203.60M derived: sum of 2 quarters · filed 2023-11-07 | $368.80M 10-Q · filed 2023-11-07 | $412.30M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $84.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $249.30M 10-Q · filed 2023-08-02 | $292.80M derived: sum of 3 quarters · filed 2024-02-15 | $478.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $165.20M 10-Q · filed 2023-05-02 | $208.70M derived: sum of 2 quarters · filed 2024-02-15 | $394.00M derived: sum of 3 quarters · filed 2024-02-15 | $341.50M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $43.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $228.80M derived: sum of 2 quarters · filed 2024-02-15 | $176.30M derived: sum of 3 quarters · filed 2024-02-15 | $274.70M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $185.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $132.80M derived: sum of 2 quarters · filed 2022-10-28 | $231.20M 10-Q · filed 2022-10-28 | $231.17M 10-Q · filed 2021-11-03 | $303.41M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | -$52.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $45.90M 10-Q · filed 2022-08-05 | $45.85M 10-Q · filed 2021-07-30 | $118.11M derived: sum of 3 quarters · filed 2023-02-10 | $105.16M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | $98.40M 10-Q · filed 2022-05-06 | $98.37M 10-Q · filed 2021-04-30 | $170.61M derived: sum of 2 quarters · filed 2023-02-10 | $157.66M derived: sum of 3 quarters · filed 2023-02-10 | $98.13M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $72.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $59.26M derived: sum of 2 quarters · filed 2023-02-10 | -$272.00K derived: sum of 3 quarters · filed 2023-02-10 | $223.40M 10-K · filed 2023-02-10 | $223.44M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | -$12.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$72.48M derived: sum of 2 quarters · filed 2021-11-03 | $151.19M 10-Q · filed 2021-11-03 | $335.35M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | -$59.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $164.14M 10-Q · filed 2021-07-30 | $348.30M derived: sum of 3 quarters · filed 2022-02-09 | $333.87M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $223.67M 10-Q · filed 2021-04-30 | $407.83M derived: sum of 2 quarters · filed 2022-02-09 | $393.40M derived: sum of 3 quarters · filed 2022-02-09 | $419.14M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $184.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $169.73M derived: sum of 2 quarters · filed 2022-02-09 | $195.46M derived: sum of 3 quarters · filed 2022-02-09 | $225.60M 10-K · filed 2022-02-09 | $225.59M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | -$14.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $11.31M derived: sum of 2 quarters · filed 2020-10-30 | $41.44M 10-Q · filed 2020-10-30 | $74.43M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $25.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $55.87M 10-Q · filed 2020-07-31 | $88.86M derived: sum of 3 quarters · filed 2021-02-11 | $75.86M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $30.14M 10-Q · filed 2020-05-01 | $63.12M derived: sum of 2 quarters · filed 2021-02-11 | $50.12M derived: sum of 3 quarters · filed 2021-02-11 | $124.81M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $32.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $19.99M derived: sum of 2 quarters · filed 2021-02-11 | $94.68M derived: sum of 3 quarters · filed 2021-02-11 | $108.15M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | -$13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $61.69M derived: sum of 2 quarters · filed 2019-10-31 | $75.17M 10-Q · filed 2019-10-31 | $86.76M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $74.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $88.17M 10-Q · filed 2019-08-01 | $99.76M derived: sum of 3 quarters · filed 2020-02-13 | $110.16M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $13.47M 10-Q · filed 2019-05-01 | $25.07M derived: sum of 2 quarters · filed 2020-02-13 | $35.47M derived: sum of 3 quarters · filed 2020-02-13 | $77.43M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $11.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $21.99M derived: sum of 2 quarters · filed 2020-02-13 | $63.96M derived: sum of 3 quarters · filed 2020-02-13 | $71.76M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $10.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $52.37M derived: sum of 2 quarters · filed 2018-10-25 | $60.16M 10-Q · filed 2018-10-25 | $54.45M 10-Q · filed 2017-10-30 | $89.50M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | $41.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $49.77M 10-Q · filed 2018-07-26 | $41.45M 10-Q · filed 2017-07-28 | $79.10M derived: sum of 3 quarters · filed 2019-02-13 | $75.91M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-03-31 | $7.80M 10-Q · filed 2018-04-27 | $5.12M 10-Q · filed 2017-04-28 | $37.13M derived: sum of 2 quarters · filed 2019-02-13 | $33.94M derived: sum of 3 quarters · filed 2019-02-13 | $44.38M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | $29.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $26.14M derived: sum of 2 quarters · filed 2019-02-13 | $36.58M derived: sum of 3 quarters · filed 2019-02-13 | $39.09M 10-K · filed 2019-02-13 | $33.03M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $7.25M derived: sum of 2 quarters · filed 2017-10-30 | $9.76M 10-Q · filed 2017-10-30 | $31.12M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $10.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $12.95M 10-Q · filed 2017-07-28 | $34.32M derived: sum of 3 quarters · filed 2018-02-15 | $101.86M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $2.51M 10-Q · filed 2017-04-28 | $23.88M derived: sum of 2 quarters · filed 2018-02-15 | $91.41M derived: sum of 3 quarters · filed 2018-02-15 | $106.75M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $21.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $88.90M derived: sum of 2 quarters · filed 2018-02-15 | $104.23M derived: sum of 3 quarters · filed 2018-02-15 | $110.10M 10-K · filed 2018-02-15 | $104.85M 10-K · filed 2016-02-16 | |||
| 2015-09-30 | $67.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $82.87M derived: sum of 2 quarters · filed 2016-10-31 | $88.73M 10-Q · filed 2016-10-31 | $73.99M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $15.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $21.20M 10-Q · filed 2016-08-01 | $6.45M derived: sum of 3 quarters · filed 2017-02-23 | $16.29M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $5.86M 10-Q · filed 2016-05-03 | -$8.88M derived: sum of 2 quarters · filed 2017-02-23 | $953.00K derived: sum of 3 quarters · filed 2017-02-23 | $23.67M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$14.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$4.91M derived: sum of 2 quarters · filed 2017-02-23 | $17.81M derived: sum of 3 quarters · filed 2017-02-23 | -$7.43M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $9.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $32.55M derived: sum of 2 quarters · filed 2015-10-30 | $7.32M 10-Q · filed 2015-10-30 | -$25.31M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $22.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$2.52M 10-Q · filed 2015-08-04 | -$35.14M derived: sum of 3 quarters · filed 2016-02-16 | -$74.34M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | -$25.24M 10-Q · filed 2015-05-04 | -$57.86M derived: sum of 2 quarters · filed 2016-02-16 | -$97.06M derived: sum of 3 quarters · filed 2016-02-16 | -$127.43M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | -$32.63M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | -$71.83M derived: sum of 2 quarters · filed 2016-02-16 | -$102.20M derived: sum of 3 quarters · filed 2016-02-16 | -$53.36M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | -$39.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$69.57M derived: sum of 2 quarters · filed 2014-11-06 | -$20.74M 10-Q · filed 2014-11-06 | -$17.11M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$30.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $18.46M 10-Q · filed 2014-07-31 | $22.09M derived: sum of 3 quarters · filed 2015-02-13 | -$23.93M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $48.83M 10-Q · filed 2014-05-05 | $52.46M derived: sum of 2 quarters · filed 2015-02-13 | $6.44M derived: sum of 3 quarters · filed 2015-02-13 | -$40.17M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$42.40M derived: sum of 2 quarters · filed 2015-02-13 | -$89.00M derived: sum of 3 quarters · filed 2015-02-13 | -$39.91M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | -$46.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$92.63M derived: sum of 2 quarters · filed 2013-11-07 | -$43.54M 10-Q · filed 2013-11-07 | -$306.06M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | -$46.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $2.48M 10-Q · filed 2013-08-02 | -$260.04M derived: sum of 3 quarters · filed 2014-02-11 | $89.38M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $49.09M 10-Q · filed 2013-05-08 | -$213.43M derived: sum of 2 quarters · filed 2014-02-11 | $135.99M derived: sum of 3 quarters · filed 2014-02-11 | $226.62M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | -$262.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $86.89M derived: sum of 2 quarters · filed 2014-02-11 | $177.53M derived: sum of 3 quarters · filed 2014-02-11 | $170.61M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $349.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $440.05M derived: sum of 2 quarters · filed 2012-11-06 | $433.13M 10-Q · filed 2012-11-06 | $440.70M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $90.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $83.71M 10-Q · filed 2012-08-08 | $91.28M derived: sum of 3 quarters · filed 2013-03-01 | $92.68M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$6.92M 10-Q · filed 2012-05-10 | $642.00K derived: sum of 2 quarters · filed 2013-03-01 | $2.05M derived: sum of 3 quarters · filed 2013-03-01 | -$2.29M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $7.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $8.97M derived: sum of 2 quarters · filed 2013-03-01 | $4.64M derived: sum of 3 quarters · filed 2013-03-01 | $2.92M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$2.93M derived: sum of 2 quarters · filed 2011-11-03 | -$4.64M 10-Q · filed 2011-11-03 | -$5.21M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | -$4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$6.04M 10-Q · filed 2011-08-09 | -$6.62M derived: sum of 3 quarters · filed 2012-02-22 | -$11.20M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | -$1.71M 10-Q · filed 2011-05-06 | -$2.29M derived: sum of 2 quarters · filed 2012-02-22 | -$6.87M derived: sum of 3 quarters · filed 2012-02-22 | -$8.83M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | -$572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$5.16M derived: sum of 2 quarters · filed 2012-02-22 | -$7.12M derived: sum of 3 quarters · filed 2012-02-22 | -$13.90M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | -$4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$6.54M derived: sum of 2 quarters · filed 2010-10-28 | -$13.33M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | -$8.74M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | -$6.79M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | -$7.83M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |